More and more research into Hyperbaric Oxygen Therapy (HBOT) as a treatment for Long COVID has delivered encouraging results, highlighting its potential as an effective intervention for alleviating persistent symptoms. Briefly, here are some of the key findings:

• Symptom Improvement: A number of studies have reported that HBOT can lead to significant improvements in symptoms associated with Long COVID, including fatigue, cognitive impairment, and shortness of breath. Patients undergoing HBOT have shown better physical and cognitive function compared to control groups.
• Inflammation Reduction: HBOT has been found to reduce markers of inflammation, which are often elevated in Long COVID patients. This anti-inflammatory effect may contribute to the alleviation of persistent symptoms.
• Enhanced Oxygen Delivery: By increasing the amount of oxygen dissolved in the blood, HBOT can improve tissue oxygenation, which may help in the recovery of organs and tissues affected by the virus.
• Neurocognitive Benefits: Some research suggests that HBOT may enhance neurocognitive functions in Long COVID patients, potentially by improving cerebral blood flow and reducing brain inflammation.
• Safety and Tolerability: Studies have found HBOT to be safe and well-tolerated by Long COVID patients, with few adverse effects reported.

The below, downloadable document reviews much of the available scientific evidence regarding the efficacy of HBOT as an effective treatment for Long Covid.